|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
PPD, Inc. (PPDI) Earns Highest Ratings for Customer Loyalty and Overall Value Among Phase I Providers in ISR Report
8/1/2012 9:11:11 AM
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) has earned the highest ratings in customer loyalty, overall value and several other attributes for Phase I services according to an Industry Standard Research (ISR) study, which evaluated 12 Phase I providers across nine key areas. In its new report, “2012 CRO Quality Benchmarking – Phase I Service Providers,” ISR surveyed 61 pharmaceutical executives responsible for Phase I outsourcing. In the survey, PPD received the highest rating for customer loyalty, a result of its top scores for overall satisfaction, willingness to recommend and likelihood to use again. In addition, PPD received the highest marks for five of ISR’s nine service attributes, including overall value, technical expertise, breadth of services, meeting schedules and timelines, and quality of the Phase I unit’s lead investigator—demonstrating that the company’s performance surpasses customer expectations.
|
|
|
|
|
|
|
|
|
|
|